Proposal for market assessment and feasibility study on cyclic peptide extracts for the companion animal feed market

本技术涉及从亚麻油中获得的环肽提取物在体内和体外观察到的生物学效应。 这种提取物作为天然健康产品在动物和人类健康市场上可能具有重大吸引力，因为已经证明具有抗炎，抗寄生虫和抗微生物活性的迹象。 萨斯喀彻温大学工业联络办公室（ILO）已经完成了初步评估，并得出结论认为，有受保护的知识产权，并在伴侣动物天然保健产品市场有很好的商业化机会。本提案是关于由劳工组织执行的市场评估计划。这项市场评估研究的结果将是商业化战略的基础，（许可给现有公司或创建一个初创公司？）。 该研究还将通过提供有关哪些属性将提高最终产品的适销性（独特的益处，新颖的作用模式）的信息，并确定营养保健品伴侣动物市场和动物饲料行业的潜在制造和其他商业化合作伙伴，为产品开发提供帮助。研究人员将申请NSERC I2I第一阶段资金，以完成生物活性材料的全面功效和毒理学研究。市场研究的可用性是向NSERC I2I申请的要求。

This technology pertains to biological effects observed in vivo and in vitro of a cyclic peptide extract obtained from flax oil. This extract may have major appeal in both animal and human health markets as natural health products, as there are demonstrated indications of anti-inflammatory, anti-parasitic and anti-microbial activity. The University of Saskatchewan Industry Liaison Office (ILO) has completed a preliminary assessment and concluded there is protectable intellectual property and that there are promising commercialization opportunities in the companion animal natural health products market. This proposal is for a Market Assessment Plan to be performed by the ILO. The outcome of this market assessment study will be the foundation for a commercialization strategy, (license to an existing company or create a start-up company?). The study will also provide assistance in product development by supplying information on what attributes would improve the marketability of the end product (unique benefits, novel modes of action) and identify potential manufacturing and other commercialization partners in the nutraceutical companion animal markets and the animal feed industry. The researchers will apply for NSERC I2I Phase 1 funding to complete the comprehensive efficacy and toxicological studies for the biologically active materials. Availability of a market study is a requirement for this application to NSERC I2I.